Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing 51 - 75 of 513
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic

Not yet recruiting
  • NSCLC
  • +5 more
  • single fraction stereotactic radiosurgery (SSRS)
  • fractionated stereotactic radiosurgery (FSRS)
  • (no location specified)
Jan 18, 2023

Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)

Recruiting
  • Metastatic Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
Jan 26, 2023

Von Hippel-Lindau: Clinical Manifestations, Diagnosis,

Recruiting
  • Kidney Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

    Not yet recruiting
    • Renal Cell Carcinoma
    • +2 more
    • Implantable Microdevice (IMD)
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Jan 17, 2023

    Solid Tumor, Non Small Cell Lung Cancer, Melanoma Trial in Lafayette, Boston, Nashville (AB248, Pembrolizumab)

    Recruiting
    • Solid Tumor
    • +4 more
    • AB248
    • Pembrolizumab
    • Lafayette, Indiana
    • +2 more
    Jan 25, 2023

    Blood, Bone Marrow, Tumor, or Tissue Samples From Cancer to

    Recruiting
    • Renal Cell Carcinoma
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

      Active, not recruiting
      • Renal Cell Carcinoma
      • La Jolla, California
      • +159 more
      Jan 23, 2023

      Renal Cancer, Renal Cell Carcinoma, Renal Cell Cancer Metastatic Trial

      Recruiting
      • Renal Cancer
      • +2 more
        • Amsterdam, Noord Holland, Netherlands
          Amsterdam UMC locatie VUMC
        Jan 20, 2023

        Japanese RCC Patients Treated With Avelumab Plus Axitinib as

        Not yet recruiting
        • Renal Cell Carcinoma
        • (no location specified)
        Jan 18, 2023

        Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

        Recruiting
        • Advanced Solid Tumor
        • +6 more
        • vobramitamab duocarmazine
        • lorigerlimab
        • Los Angeles, California
        • +7 more
        Jan 10, 2023

        Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

        Terminated
        Has Results
        • Renal Cell Carcinoma
        • Nivolumab
        • Ipilimumab
        • Saint Louis, Missouri
        • +11 more
        Dec 15, 2022

        Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Ipilimumab, Ipilimumab )

        Active, not recruiting
        • Renal Cell Carcinoma
        • Nivolumab
        • +2 more
        • Washington, District of Columbia
        • +77 more
        Jan 6, 2023

        Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

        Completed
        • Mesothelioma
        • +3 more
        • Gainesville, Florida
        • +2 more
        Jan 4, 2023

        Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,

        Recruiting
        • Advanced Solid Tumor
        • +10 more
        • Boston, Massachusetts
        • +8 more
        Jan 2, 2023

        Renal Cell Carcinoma Trial (Neoadjuvant Lenvatinib, Neoadjuvant Pembrolizumab, Radical nephrectomy, IVC thrombectomy,

        Not yet recruiting
        • Renal Cell Carcinoma
        • Neoadjuvant Lenvatinib
        • +3 more
        • (no location specified)
        Dec 23, 2022

        Gastric Cancer, Renal Cell Carcinoma, Melanoma Trial in United States (HFB200301)

        Recruiting
        • Gastric Cancer
        • +8 more
        • Scottsdale, Arizona
        • +9 more
        Dec 22, 2022

        Urothelial Carcinoma, Renal Cell Carcinoma, Melanoma Trial (BGB-A445, Tislelizumab)

        Not yet recruiting
        • Urothelial Carcinoma
        • +2 more
        • (no location specified)
        Dec 15, 2022

        Renal Cell Carcinoma Trial in Haifa (PROSENSE™)

        Active, not recruiting
        • Renal Cell Carcinoma
        • PROSENSE™
        • Haifa, Israel
        • +1 more
        Dec 21, 2022

        Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029

        Terminated
        Has Results
        • Colorectal Cancer
        • +6 more
        • GEN1029 (HexaBody®-DR5/DR5)
        • New Haven, Connecticut
        • +5 more
        Nov 11, 2022

        Recurrent Renal Cell Carcinoma, Renal Cell Carcinoma Trial in Philadelphia (drug, procedure, other)

        Recruiting
        • Recurrent Renal Cell Carcinoma
        • Renal Cell Carcinoma
        • Sulfur Hexafluoride Lipid Microspheres
        • +4 more
        • Philadelphia, Pennsylvania
          Sidney Kimmel Cancer Center at Thomas Jefferson University
        Nov 29, 2022

        Renal Cell Carcinoma Trial in Houston (Perfusion CT scan)

        Active, not recruiting
        • Renal Cell Carcinoma
        • Perfusion CT scan
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        Dec 6, 2022

        Renal Cell Carcinoma Trial in Wuxi (68Ga-NY104)

        Recruiting
        • Renal Cell Carcinoma
        • Wuxi, Jiangsu, China
          Affiliated Hospital of Jiangnan University
        Nov 27, 2022

        Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

        Recruiting
        • Kidney Cancer
        • +11 more
        • 13C-Glucose
        • +4 more
        • Dallas, Texas
          University of Texas Southwestern Medical Center
        Dec 1, 2022

        Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

        Completed
        • Melanoma
        • +27 more
        • XmAb20717
        • Los Angeles, California
        • +16 more
        Nov 29, 2022

        Implementation of Shared Decision Making Strategy for Renal Cell

        Recruiting
        • Renal Cell Carcinoma
        • Renal Cell Carcinoma Metastatic
        • Decision aid
        • Nieuwegein, Utrecht, Netherlands
          St. Antonius Ziekenhuis
        Nov 28, 2022